Davide Campari-Milano N.V. (BIT:CPR)
Italy
· Delayed Price · Currency is EUR 6.27
+0.05 (0.84%)
Apr 28, 2026, 5:35 PM CET
Davide Campari-Milano Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Other Revenue | 0.1 | -0.1 | - | - | - | Upgrade
|
| Revenue | 3,051 | 3,070 | 2,919 | 2,698 | 2,173 | Upgrade
|
| Revenue Growth (YoY) | -0.60% | 5.18% | 8.19% | 24.16% | 22.61% | Upgrade
|
| Cost of Revenue | 1,211 | 1,277 | 1,219 | 1,109 | 875.8 | Upgrade
|
| Gross Profit | 1,840 | 1,792 | 1,700 | 1,589 | 1,297 | Upgrade
|
| Selling, General & Admin | 1,199 | 1,197 | 1,096 | 1,041 | 861.6 | Upgrade
|
| Other Operating Expenses | - | - | - | - | 15.4 | Upgrade
|
| Operating Expenses | 1,199 | 1,197 | 1,096 | 1,041 | 877 | Upgrade
|
| Operating Income | 640.7 | 594.9 | 604.3 | 547.5 | 419.9 | Upgrade
|
| Interest Expense | -105.3 | -110.1 | -70.8 | -31.5 | -28.3 | Upgrade
|
| Interest & Investment Income | 16.6 | 38 | 23.5 | 15.1 | 11.9 | Upgrade
|
| Earnings From Equity Investments | 2.9 | -34.8 | -8.3 | -6.6 | -0.1 | Upgrade
|
| Currency Exchange Gain (Loss) | -1 | -9 | -19.2 | -4.6 | 7.9 | Upgrade
|
| Other Non Operating Income (Expenses) | -11.5 | -7.8 | -7.8 | -9.6 | -4.2 | Upgrade
|
| EBT Excluding Unusual Items | 542.4 | 471.2 | 521.7 | 510.3 | 407.1 | Upgrade
|
| Merger & Restructuring Charges | - | -114.9 | -36.6 | -11.4 | -10.6 | Upgrade
|
| Gain (Loss) on Sale of Investments | -59.4 | -24.7 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 55.3 | - | - | - | -1.3 | Upgrade
|
| Asset Writedown | -90 | -56.8 | -11.9 | -6.6 | -8 | Upgrade
|
| Other Unusual Items | 12.1 | -19.2 | -6.7 | -17.3 | -3.4 | Upgrade
|
| Pretax Income | 460.4 | 255.6 | 466.5 | 475 | 388.6 | Upgrade
|
| Income Tax Expense | 127.3 | 63 | 134 | 143.5 | 105.6 | Upgrade
|
| Earnings From Continuing Operations | 333.1 | 192.6 | 332.5 | 331.5 | 283 | Upgrade
|
| Minority Interest in Earnings | 13.2 | 9 | -2 | 1.5 | 1.8 | Upgrade
|
| Net Income | 346.3 | 201.6 | 330.5 | 333 | 284.8 | Upgrade
|
| Net Income to Common | 346.3 | 201.6 | 330.5 | 333 | 284.8 | Upgrade
|
| Net Income Growth | 71.78% | -39.00% | -0.75% | 16.92% | 51.57% | Upgrade
|
| Shares Outstanding (Basic) | 1,200 | 1,200 | 1,128 | 1,126 | 1,127 | Upgrade
|
| Shares Outstanding (Diluted) | 1,259 | 1,251 | 1,139 | 1,140 | 1,146 | Upgrade
|
| Shares Change (YoY) | 0.68% | 9.79% | -0.09% | -0.53% | -0.86% | Upgrade
|
| EPS (Basic) | 0.29 | 0.17 | 0.29 | 0.30 | 0.25 | Upgrade
|
| EPS (Diluted) | 0.29 | 0.17 | 0.29 | 0.29 | 0.25 | Upgrade
|
| EPS Growth | 70.79% | -42.09% | - | 16.00% | 56.25% | Upgrade
|
| Free Cash Flow | 426 | 246.3 | -136.9 | 41.8 | 362.7 | Upgrade
|
| Free Cash Flow Per Share | 0.34 | 0.20 | -0.12 | 0.04 | 0.32 | Upgrade
|
| Dividend Per Share | 0.100 | 0.065 | 0.065 | 0.060 | 0.060 | Upgrade
|
| Dividend Growth | 53.85% | - | 8.33% | - | 9.09% | Upgrade
|
| Gross Margin | 60.31% | 58.39% | 58.25% | 58.89% | 59.69% | Upgrade
|
| Operating Margin | 21.00% | 19.38% | 20.71% | 20.30% | 19.33% | Upgrade
|
| Profit Margin | 11.35% | 6.57% | 11.32% | 12.34% | 13.11% | Upgrade
|
| Free Cash Flow Margin | 13.96% | 8.02% | -4.69% | 1.55% | 16.69% | Upgrade
|
| EBITDA | 750.2 | 687.6 | 682.2 | 607.6 | 471.8 | Upgrade
|
| EBITDA Margin | 24.59% | 22.40% | 23.37% | 22.52% | 21.71% | Upgrade
|
| D&A For EBITDA | 109.5 | 92.7 | 77.9 | 60.1 | 51.9 | Upgrade
|
| EBIT | 640.7 | 594.9 | 604.3 | 547.5 | 419.9 | Upgrade
|
| EBIT Margin | 21.00% | 19.38% | 20.71% | 20.30% | 19.33% | Upgrade
|
| Effective Tax Rate | 27.65% | 24.65% | 28.72% | 30.21% | 27.17% | Upgrade
|
| Revenue as Reported | 3,051 | 3,070 | 2,919 | 2,698 | 2,173 | Upgrade
|
| Advertising Expenses | 547.1 | 513.3 | 494.1 | 479 | 397.8 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.